Vaccines, Testing, and Treatment: As a result of the American Rescue Plan Act of 2021 (ARPA), states must provide Medicaid and CHIP coverage without cost sharing for COVID-19 vaccinations, testing, and treatments through the last day of the first calendar quarter that begins one year after the last day of the COVID-19 PHE. Generally, the end of the COVID-19 PHE does not change access to oral antivirals, such as Paxlovid and Lagevrio. Treatments: There is no change in Medicare coverage of treatments for those exposed to COVID-19 once the PHE ends, and in cases where cost sharing and deductibles apply now, they will continue to apply. However, some Medicare Advantage plans may continue to provide coverage as a supplemental benefit. Current access to free over-the-counter COVID-19 tests will end with the end of the PHE. By law, Medicare does not generally cover over-the-counter services and tests. People enrolled in Medicare Advantage (MA) plans can continue to receive COVID-19 PCR and antigen tests when the test is covered by Medicare, but their cost-sharing may change when the PHE ends. Testing: Additionally, people with traditional Medicare can continue to receive COVID-19 PCR and antigen tests with no cost sharing when the test is ordered by a physician or certain other health care providers, such as physician assistants and certain registered nurses, and performed by a laboratory. Vaccines: People with Medicare coverage will continue to have access to COVID-19 vaccinations without cost sharing after the end of the PHE. ĬOVID-19 vaccines, testing, and treatments For more information on what changes and does not change across the Department, visit. ![]() There are significant flexibilities and actions that will not be affected as we transition from the current phase of our response. As described in previous communications, the Administration’s continued response is not entirely dependent on the COVID-19 PHE. ![]() The Administration, States, and private insurance plans will continue to provide guidance in the coming months. Inpatient Hospital Care at Home: Expanded hospital capacity by providing inpatient care in a patient’s home.Health Care Access: Continuing flexibilities for health care professionals and.COVID-19 vaccines, testing, and treatments.This fact sheet will cover the following: ![]() Please note that this information is not intended to cover every possible scenario. This fact sheet will help you know what to expect at the end of the PHE so that you can continue to feel confident in how you will receive your health care. While some of these changes will be permanent or extended due to Congressional action, some waivers and flexibilities will expire, as they were intended to respond to the rapidly evolving pandemic, not to permanently replace standing rules. Health care providers received maximum flexibility to streamline delivery and allow access to care during the PHE. The emergency declarations, legislative actions by Congress, and regulatory actions across government, including by the Centers for Medicare & Medicaid Services (CMS), allowed for changes to many aspects of health care delivery during the COVID-19 PHE. Thanks to the Administration’s whole-of-government approach to combatting the virus, we are in a better place in our response than we were three years ago, and we can transition away from an emergency phase. Based on current COVID-19 trends, the Department of Health and Human Services is planning for the federal Public Health Emergency for COVID-19 (PHE), declared under Section 319 of the Public Health Service Act, to expire at the end of the day on.
0 Comments
Leave a Reply. |